DE69723580D1 - Impfstoff gegen metastasierenden kolorektalkrebs. - Google Patents

Impfstoff gegen metastasierenden kolorektalkrebs.

Info

Publication number
DE69723580D1
DE69723580D1 DE69723580T DE69723580T DE69723580D1 DE 69723580 D1 DE69723580 D1 DE 69723580D1 DE 69723580 T DE69723580 T DE 69723580T DE 69723580 T DE69723580 T DE 69723580T DE 69723580 D1 DE69723580 D1 DE 69723580D1
Authority
DE
Germany
Prior art keywords
colorectal cancer
metastatic colorectal
vaccine against
against metastatic
individuals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69723580T
Other languages
English (en)
Other versions
DE69723580T2 (de
Inventor
A Waldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Application granted granted Critical
Publication of DE69723580D1 publication Critical patent/DE69723580D1/de
Publication of DE69723580T2 publication Critical patent/DE69723580T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69723580T 1996-05-03 1997-05-02 Impfstoff gegen metastasierenden kolorektalkrebs. Expired - Lifetime DE69723580T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1701896P 1996-05-03 1996-05-03
US17018P 1996-05-03
PCT/US1997/007565 WO1997042220A1 (en) 1996-05-03 1997-05-02 Metastatic colorectal cancer vaccine

Publications (2)

Publication Number Publication Date
DE69723580D1 true DE69723580D1 (de) 2003-08-21
DE69723580T2 DE69723580T2 (de) 2004-06-03

Family

ID=21780270

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69723580T Expired - Lifetime DE69723580T2 (de) 1996-05-03 1997-05-02 Impfstoff gegen metastasierenden kolorektalkrebs.

Country Status (6)

Country Link
US (2) US7598229B2 (de)
EP (1) EP0951475B1 (de)
AT (1) ATE245163T1 (de)
CA (1) CA2254082C (de)
DE (1) DE69723580T2 (de)
WO (1) WO1997042220A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69723580T2 (de) * 1996-05-03 2004-06-03 Thomas Jefferson University Impfstoff gegen metastasierenden kolorektalkrebs.
US6113815A (en) * 1997-07-18 2000-09-05 Bioshield Technologies, Inc. Ether-stabilized organosilane compositions and methods for using the same
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
AU7700400A (en) * 1999-10-06 2001-05-10 Pharmacia Corporation Uroguanylin as an intestinal cancer inhibiting agent
CA2404428A1 (en) 2000-03-27 2001-10-04 Thomas Jefferson University High specificity marker detection
AU2001292728A1 (en) 2000-09-18 2002-03-26 Thomas Jefferson University Compositions and methods for identifying and targeting stomach and esophageal cancer cells
WO2004071436A2 (en) 2003-02-10 2004-08-26 Thomas Jefferson University The use of gcc ligands
WO2010036652A1 (en) * 2008-09-23 2010-04-01 Thomas Jefferson University Cancer vaccines against mucosal antigens and methods of making and using the same
EP2491116A4 (de) 2009-10-22 2013-12-11 Univ Jefferson Zellbasierte antikrebszusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
TWI483736B (zh) 2009-10-23 2015-05-11 Millennium Pharm Inc 抗－ｇｃｃ抗體分子及其相關之組合物及方法
HUE046404T2 (hu) 2012-04-27 2020-02-28 Millennium Pharm Inc GCC elleni ellenanyag-molekulák és alkalmazásuk GCC-t célzó terápiára való érzékenység tesztelésére

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1945050A (en) 1932-03-30 1934-01-30 Louis H Larsen Automatic stoker
US4375414A (en) 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4022878A (en) 1972-05-15 1977-05-10 Biological Developments, Inc. Methods and compounds for producing specific antibodies
US4526716A (en) 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
JPS62162963A (ja) 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
DE3806565A1 (de) 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AU5344190A (en) 1989-03-21 1990-10-22 Vical, Inc. Expression of exogenous polynucleotide sequences in a vertebrate
US5237051A (en) 1990-12-06 1993-08-17 Vanderbilt University Purified enterotoxin receptor protein
US5352775A (en) 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
CA2174928C (en) * 1993-10-26 2011-08-16 Scott A. Waldman Compositions that specifically bind to colorectal cancer cells and methods of using the same
US5518888A (en) 1993-10-26 1996-05-21 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5879656A (en) 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US5601990A (en) 1994-09-13 1997-02-11 Thomas Jefferson University Methods of diagnosing colorectal tumors and metastasis thereof
DE69723580T2 (de) * 1996-05-03 2004-06-03 Thomas Jefferson University Impfstoff gegen metastasierenden kolorektalkrebs.

Also Published As

Publication number Publication date
CA2254082C (en) 2012-09-11
CA2254082A1 (en) 1997-11-13
EP0951475A4 (de) 2001-03-28
US8329881B2 (en) 2012-12-11
DE69723580T2 (de) 2004-06-03
US20040141990A1 (en) 2004-07-22
EP0951475A1 (de) 1999-10-27
US20100196408A1 (en) 2010-08-05
WO1997042220A1 (en) 1997-11-13
US7598229B2 (en) 2009-10-06
EP0951475B1 (de) 2003-07-16
ATE245163T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
NO983999D0 (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
DK0768885T3 (da) Fremgangsmåde til inhibering af cancermetastase ved oral administration af oplöselig modificeret citruspectin
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
AU2001251613A1 (en) Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
NO983512D0 (no) Midler for behandling og forhindring av AIDS
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
BR0111785A (pt) Composições e métodos para tratamento de candidìase
NO20030593D0 (no) Fremgangsmåter for behandling av cancer og smerten forbundet derved ved å anvende endotelinantagonister
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
AU1991901A (en) Pharmaceutical composition for treating and preventing human tumors, which express the tumor antigen mucin and/or the carcinoembryonic antigen (cea), and the use thereof
AU2001245939A1 (en) Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001247560A8 (en) Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers
AU2001259160A1 (en) Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
GB9704046D0 (en) Arrestable therapeutic
DE69807166D1 (de) Prostata-spezifische Antigen Inhibitore

Legal Events

Date Code Title Description
8364 No opposition during term of opposition